Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urine Resazurin Reduction Ratio and Phenotypic Antibiotic Susceptibility Testing: A Rapid Diagnostic Tool for Urinary Tract Infection and Lower Urinary Tract Dysfunction Using a Catheter

NCT07784829 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT07784829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07784829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urine Resazurin Reduction Ratio and Phenotypic Antibiotic Susceptibility Testing: A Rapid Diagnostic Tool for Urinary Tract Infection and Lower Urinary Tract Dysfunction Using a Catheter
Lead sponsor
Medstar Health Research Institute
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
July 31, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lower urinary tract disorder, neurogenic bladder disorder, urinary tract infection (diagnosis)